Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents-Reference-Cited by-同舟云学术

Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents

Published:2017-11-22 Issue: Volume: Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Ahn Shin,Rice Terry W.,Yeung Sai-ching J.,Cooksley Tim^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-017-3985-0.pdf

Reference24 articles.

1. Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J, ESMO Guidelines Committee (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27(Suppl 5):v111–v118. https://doi.org/10.1093/annonc/mdw325

2. Friefeld A, Bow E, Sepkowitz K et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–e93. https://doi.org/10.1093/cid/cir073

3. Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M (2006) Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol 24(25):4129–4134. https://doi.org/10.1200/JCO.2005.03.9909

4. Talcott J, Yeap B, Clark J et al (2011) Safety of early discharge for low-risk patients with febrile neutropenia: a multicentre randomized controlled trial. J Clin Oncol 29(30):3977–3988. https://doi.org/10.1200/JCO.2011.35.0884

5. Paesmans M, Klastersky J, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Ameye L (2011) Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter? Support Care Cancer 19(7):1001–1008. https://doi.org/10.1007/s00520-010-0925-7

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization;Annals of Hematology;2024-01-25

2. Ambulatory management of low-risk febrile neutropenia in adult oncological patients. Systematic review;Supportive Care in Cancer;2023-11

3. ASCO update—hepatocellular carcinoma and cholangiocellular carcinoma;memo - Magazine of European Medical Oncology;2023-10-27

4. Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?;The Journal of Emergency Medicine;2023-01

5. Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?;Thoracic Cancer;2022-11-04